Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of PLN 2.14 billion. The enterprise value is 2.92 billion.

Market Cap	2.14B
Enterprise Value	2.92B

Important Dates

The next estimated earnings date is Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	Jul 11, 2024

Share Statistics

Shares Outstanding	n/a
Shares Change (YoY)	+26.74%
Shares Change (QoQ)	+54.61%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	40.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.34, with an EV/FCF ratio of 50.88.

EV / Earnings	17.06
EV / Sales	0.68
EV / EBITDA	9.34
EV / EBIT	13.46
EV / FCF	50.88

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 44.15.

Current Ratio	1.46
Quick Ratio	0.70
Debt / Equity	44.15
Debt / EBITDA	2.98
Debt / FCF	13.92
Interest Coverage	6.11

Financial Efficiency

Return on equity (ROE) is 10.70% and return on invested capital (ROIC) is 4.40%.

Return on Equity (ROE)	10.70%
Return on Assets (ROA)	3.44%
Return on Capital (ROIC)	4.40%
Revenue Per Employee	888,064
Profits Per Employee	34,909
Employee Count	4,721
Asset Turnover	1.39
Inventory Turnover	4.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.94% in the last 52 weeks. The beta is -0.05, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+2.94%
50-Day Moving Average	13.12
200-Day Moving Average	13.51
Relative Strength Index (RSI)	60.13
Average Volume (20 Days)	281

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of PLN 4.35 billion and earned 170.91 million in profits. Earnings per share was 1.07.

Revenue	4.35B
Gross Profit	945.66M
Operating Income	171.49M
Pretax Income	201.36M
Net Income	170.91M
EBITDA	228.24M
EBIT	171.49M
Earnings Per Share (EPS)	1.07

Full Income Statement

Balance Sheet

The company has 58.05 million in cash and 797.80 million in debt, giving a net cash position of -739.75 million.

Cash & Cash Equivalents	58.05M
Total Debt	797.80M
Net Cash	-739.75M
Net Cash Per Share	n/a
Equity (Book Value)	1.81B
Book Value Per Share	10.67
Working Capital	531.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 105.44 million and capital expenditures -48.14 million, giving a free cash flow of 57.31 million.

Operating Cash Flow	105.44M
Capital Expenditures	-48.14M
Free Cash Flow	57.31M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.75%, with operating and profit margins of 3.94% and 3.93%.

Gross Margin	21.75%
Operating Margin	3.94%
Pretax Margin	4.63%
Profit Margin	3.93%
EBITDA Margin	5.25%
EBIT Margin	3.94%
FCF Margin	1.32%

Dividends & Yields

Sopharma AD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	60.26%
Years of Dividend Growth	2
Payout Ratio	273.99%
Buyback Yield	-26.74%
Shareholder Yield	-26.74%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sopharma AD has an Altman Z-Score of 3.16.

Altman Z-Score	3.16
Piotroski F-Score	n/a